15,000 volunteers from 107 nationalities living in the country participate in Corona vaccine trials
The world's first clinical trials of the third phase of the inactive Covid-19 vaccine, underway in the UAE, have achieved a new milestone with 15,000 volunteers from 107 nationalities receiving a dose of the vaccine in less than a month.
The experiments were launched on July 16 in Abu Dhabi, under the management of the "G42 Healthcare" in partnership with the Ministry of Health and Community Protection and the Department of Health - Abu Dhabi, and "Sinopharma CNBG", one of the leading vaccine manufacturers that developed the inactive vaccine.
More than 140 doctors, 300 nurses, and many administrative and technical support personnel participated in this experiment, as volunteers received regular medical examinations as well as all the necessary support to monitor and ensure their safety.
The participation of 15,000 people in this clinical trial of the third phase of the inactive vaccine for the virus / Covid-19 / is a global achievement, as the world approaches the first safe vaccine that has been tested and developed at the highest level of international scientific standards.
The Ministry of Health and Prevention, the Department of Health - Abu Dhabi, the "Synopharm CNBG" company, and the "G42 Healthcare" company renewed their thanks to all volunteers for their great service to humanity, stressing that without such an active and effective participation in scientific experiments it is not possible. Developing a safe vaccine.
The volunteers benefited from the ease of procedures that enabled them to enter easily and conveniently to the Abu Dhabi National Exhibition Center and Al-Qareen Center in the Emirate of Sharjah to conduct experiments .. Volunteers continue their work as they are currently receiving the second dose of the vaccine under continuous monitoring and monitoring of their health conditions, as they receive all the necessary health services to maintain For their health and safety.
Abdul Rahman bin Muhammad Al Owais, Minister of Health and Community Protection, said: “It is a day when we are proud of all those who participated in these experiences, and we look forward to continuing to play a vital role in these efforts in the coming months .. The achievement of this achievement is a living testament to the commitment and partnership of the relevant bodies that work. Together, to conduct the largest possible number of medical examinations and provide the necessary care for those infected with the infection, at the same time strengthening the UAE's cooperation with international partners to develop a safe vaccine that protects against the disease.
Sheikh Abdullah bin Muhammad Al Hamed, head of the Abu Dhabi Department of Health, who was the first to volunteer to test the vaccine in the world where he received the first and second doses of the vaccine, said: “I am very proud that I was the first to volunteer to participate in these clinical trials .. and since then it was up. It would be great to see the state with all its institutions standing up to help us reach the target number of participants in these examinations during the first four weeks of the start of the experiments ... We are a nation that is proud of the presence of extraordinary people .. people who come from all over the world and call the UAE their second home .. Together, we will remain committed to finding a global solution to the Corona pandemic. "
Dr. Nawal Al Kaabi, Executive Director of Medical Affairs at Sheikh Khalifa Medical City and Chairman of the Health Council for Infectious Diseases and Infection Control, said: “It is indeed a wonderful achievement, as the importance of participating in these clinical trials has enriched the nation’s imagination, as 15,000 volunteers applied to participate in an achievement that shows passion. And the commitment of everyone who lives and works here in the United Arab Emirates to play an effective role for the sake of the whole of humanity .. I would like to express my appreciation for the leadership of the United Arab Emirates for conducting these pioneering experiments and of course to the volunteers, clinical and administrative staff who are strongly committed to their high professionalism in dealing with volunteers with these Speed and efficiency. "
Ashish Kochi, CEO of G42 Healthcare said: “The 107 nationalities who have now volunteered are strong evidence of the correctness of the decision we have taken to encourage Sinopharma CNPG to partner with us in the UAE due to the multiethnic and diverse and broad demographics of the population. The state ... However, this achievement only indicates the completion of the phase of receiving the first dose of the volunteers .. The joint scientific and clinical teams will now work to ensure the smooth management of the 15,000 volunteers during each stage of their 42-day journey that includes regular checks and of course return to obtain A second dose of the potential vaccine. "
"The speed of these experiments to date and the amazing ethnic diversity of vaccinated volunteers have confirmed the correctness of our decision that the UAE is an ideal location to test our potential vaccine and reach the widest population and ethnic group of people," said Jing Jin Zhu, Head of Biological Products at Synopharma CNBG. Volunteers. "
He added, "We would like to thank our partners G42 Healthcare and the health authorities in the United Arab Emirates for their hard work and professionalism, and we look forward to continuing success as trials continue in the coming weeks and months."
At the same time, "G42 Healthcare" has expanded the cycle of the first trials in the world for the third phase of the inactive vaccine for "Covid-19" from Sinopharma CNBG to include a new center in Bahrain that is currently witnessing the delivery of the vaccine to the first group of volunteers in the Kingdom .
This trial is part of a series of national initiatives to enhance population health and enhance medical research and development capabilities in the UAE, including the local capacity to manufacture the vaccine.
Work is underway to open more centers in additional locations to ensure the participation of the largest number of individuals and join the "For Humanity" campaign.